Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 4,109 | 3,943 | 4,180 | 4,248 | 3,495 |
| Operating Income | -4,109 | -3,943 | -4,180 | -4,248 | -3,495 |
| Other Income | 94 | 137 | 177 | 326 | 250 |
| Pre-tax Income | -4,015 | -3,807 | -4,003 | -3,922 | -3,245 |
| Net Income Continuous | -4,015 | -3,807 | -4,003 | -3,922 | -3,245 |
| Net Income | $-4,015 | $-3,807 | $-4,003 | $-3,922 | $-3,245 |
| EPS Basic Total Ops | -13.16 | -12.61 | -12.89 | -13.17 | -10.92 |
| EPS Basic Continuous Ops | -13.16 | -12.63 | -13.35 | -13.08 | -10.82 |
| EPS Diluted Total Ops | -13.16 | -12.61 | -12.89 | -13.17 | -10.92 |
| EPS Diluted Continuous Ops | -13.16 | -12.63 | -13.35 | -13.08 | -10.82 |
| EPS Diluted Before Non-Recurring Items | -13.17 | -12.61 | -13.17 | N/A | N/A |
| EBITDA(a) | $-4,109 | $-3,943 | $-4,179 | $-4,248 | $-3,495 |